DexCom (DXCM) Misses Q2 EPS by 12c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
DexCom (DXCM) PT Raised to $100 at Piper Jaffray
August 3, 2016 7:59 AM EDTPiper Jaffray analyst Brooks West reiterated an Overweight rating and raised his price target on DexCom (NASDAQ: DXCM) to $100.00 (from $93.00) on German reimbursement and positive FDA Panel.
West commented, "DexCom reported $137.3M (+47%) in 2Q16 revenue, ahead of consensus $132.5M but below the... More
